Skip to Main Content

Paper Details

Evaluation of <sup>177</sup>Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective <sup>177</sup>Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).
J Nucl Med
12
2023
Author NameAffiliation
Anthony M JoshuaKinghorn Cancer Centre, St. Vincent's Hospital
Anthony M JoshuaGarvan Institute of Medical Research
Anthony M JoshuaSt. Vincent's Clinical School, University of New South Wales
  • 1 - 3

Datasets

Release 1.2